Tetrahydrobiopterin (BH4) biosynthesis and regeneration

Tetrahydrobiopterin (BH4, (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin) is an essential reduced-pteridine cofactor for the aromatic amino acid hydroxylases (phenylalanine hydroxylase PAH, tyrosine hydroxylase TH, and the tryptophan hydroxylases TPH1/TPH2), for the nitric oxide synthases, and for alkylglycerol monooxygenase. This module covers the two arms of BH4 homeostasis. (1) De novo biosynthesis, a short cytosolic three-step pathway from GTP: GTP cyclohydrolase I (GCH1) opens the imidazole ring of GTP to give 7,8-dihydroneopterin 3'-triphosphate (the committed, feedback-regulated step); 6-pyruvoyltetrahydropterin synthase (PTS/PTPS) converts this to 6-pyruvoyl-5,6,7,8-tetrahydropterin; and sepiapterin reductase (SPR) carries out the NADPH-dependent reductions that yield BH4. (2) Regeneration (recycling), which is required because each turn of an aromatic amino acid hydroxylase oxidises BH4 to pterin-4a-carbinolamine (4a-hydroxy-BH4): pterin-4a-carbinolamine dehydratase (PCBD1/PCD) dehydrates this to quinonoid dihydrobiopterin, and dihydropteridine reductase (QDPR/DHPR) reduces the quinonoid dihydrobiopterin back to BH4 using NADH. Because the hydroxylases turn over far faster than de novo synthesis, the PCBD1-QDPR salvage loop supplies most of the BH4 used at steady state. Inherited defects of GCH1, PTS, SPR, PCBD1 or QDPR all cause BH4 deficiency, presenting as BH4-deficient hyperphenylalaninemia (atypical/"malignant" PKU) and/or monoamine-neurotransmitter deficiency (dopa-responsive dystonia, catecholamine and serotonin deficiency), a distinct and separately treatable group of disorders from PAH-deficient classical PKU. PCBD1 additionally moonlights as DCoH, the dimerization cofactor / transcriptional coactivator of the HNF1 transcription factors.

MODULE:tetrahydrobiopterin_metabolismDRAFTMetabolic Pathwaymodules/tetrahydrobiopterin_metabolism.yaml
tetrahydrobiopterin biosynthetic processGO:0006729 tetrahydrobiopterin metabolic processGO:0046146
GO:0006729
tetrahydrobiopterin biosynthetic process
The de novo arm is grounded in the GO biological-process term for tetrahydrobiopterin biosynthesis (GO:0006729); the whole module is scoped by tetrahydrobiopterin metabolic process (GO:0046146).
Reactome:R-HSA-1474151
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
Step order, compartmentalization and reaction stoichiometries follow the human Reactome BH4 pathway and its member reactions (R-HSA-1474146, R-HSA-1474184, R-HSA-1475414, R-HSA-71146, R-HSA-71130).
file:human/GCH1/GCH1-ai-review.yaml
GCH1 gene review (human)
The GCH1 step grounding (UniProtKB:P30793, GO:0003934 GTP cyclohydrolase I activity, EC 3.5.4.16) matches the completed human GCH1 review.
file:human/PTS/PTS-ai-review.yaml
PTS gene review (human)
The PTS step grounding (UniProtKB:Q03393, GO:0003874 6-pyruvoyltetrahydropterin synthase activity, EC 4.2.3.12) matches the completed human PTS review.
file:human/SPR/SPR-ai-review.yaml
SPR gene review (human)
The SPR step grounding (UniProtKB:P35270, GO:0004757 sepiapterin reductase (NADP+) activity, EC 1.1.1.153) matches the completed human SPR review.
file:human/PCBD1/PCBD1-ai-review.yaml
PCBD1 gene review (human)
The PCBD1/PCD regeneration step (UniProtKB:P61457, GO:0008124 4-alpha-hydroxytetrahydrobiopterin dehydratase activity, EC 4.2.1.96) matches the completed human PCBD1 review, which also captures the DCoH transcriptional-coactivator moonlighting role.
file:human/QDPR/QDPR-ai-review.yaml
QDPR gene review (human)
The QDPR/DHPR regeneration step (UniProtKB:P09417, GO:0004155 6,7-dihydropteridine reductase activity, EC 1.5.1.34) matches the completed human QDPR review.
7Nodes
6Parts
0Variant Sets
0Variants
6Annotons
6Connections

Derived QC

Recommended-field compliance

100.0% recommended fields populated

All recommended fields populated.

Module deep research

✗ none found

No MODULE:tetrahydrobiopterin_metabolism deep-research report alongside the module YAML.

Leaf nodes lacking representative members

✓ every leaf node grounds to a representative protein.

Template conformance

✓ every declared conforms_to bundle matches its template motif.

Gene-review completeness (8/10 grounded genes reviewed)

7 complete review(s) · 5 with deep research · 2 missing review · 3 reviewed but lacking deep research

Gene Review Complete Deep research
GCH1 P30793 ✓ 69/70 ✓
PAH (human, phenylalanine hydroxylase) P00439 ✗ — —
PCBD1 P61457 ✓ ✓ ✓
PTS Q03393 ✓ ✓ ✓
PCBD2 / DCoHm (human paralog) Q9H0N5 ✗ — —
QDPR P09417 ✓ ✓ ✓
SPR P35270 ✓ ✓ ✓
TH P07101 ✓ ✓ ✗
TPH1 P17752 ✓ ✓ ✗
TPH2 Q8IWU9 ✓ ✓ ✗

Details

Context
cytosolGO:0005829
Tetrahydrobiopterin (BH4) metabolismMetabolic Pathwaytetrahydrobiopterin_metabolism
tetrahydrobiopterin biosynthetic processGO:0006729 tetrahydrobiopterin metabolic processGO:0046146
Context
cytosolGO:0005829

BH4 synthesis (GCH1 -> PTS -> SPR) and regeneration (PCBD1 -> QDPR) grounded to the human enzymes GCH1 (UniProtKB:P30793, GO:0003934, EC 3.5.4.16), PTS (Q03393, GO:0003874, EC 4.2.3.12), SPR (P35270, GO:0004757, EC 1.1.1.153), PCBD1 (P61457, GO:0008124, EC 4.2.1.96) and QDPR (P09417, GO:0004155, EC 1.5.1.34). GO molecular-function terms were taken from the human GOA records; Reactome reaction ids and titles were verified against the local reactome cache. Each step uses a PANTHER family selector (generic over paralogs and orthologs) plus a concrete human representative member; the PCBD1 family lists the PCBD2/DCoHm paralog. The BH4-utilization node is included only to close the recycling loop and is grounded generically to the biopterin-dependent aromatic amino acid hydroxylase family (PAH, TH, TPH1/2). Downstream monoamine neurotransmitter synthesis (dopamine, serotonin), nitric oxide synthesis, and the DCoH/HNF1 transcriptional moonlighting role of PCBD1 are noted but out of scope for this cofactor-metabolism module.

Connections

gch1_step -> pts_step Provides Input For
7,8-dihydroneopterin 3'-triphosphate from GCH1 is the substrate of PTS.
pts_step -> spr_step Provides Input For
6-pyruvoyltetrahydropterin from PTS is reduced to BH4 by SPR.
spr_step -> aaah_utilization Provides Input For
De novo BH4 made by SPR is the reduced-pteridine cofactor consumed by the aromatic amino acid hydroxylases.
aaah_utilization -> pcbd1_step Provides Input For
Hydroxylase turnover oxidises BH4 to pterin-4a-carbinolamine, the substrate dehydrated by PCBD1.
pcbd1_step -> qdpr_step Provides Input For
Quinonoid dihydrobiopterin from PCBD1 is reduced back to BH4 by QDPR.
qdpr_step -> aaah_utilization Provides Input For
BH4 regenerated by QDPR re-enters the hydroxylase reactions, closing the recycling loop that supplies most BH4 at steady state.
Part 1: de novo synthesis, committed step
GTP to 7,8-dihydroneopterin 3'-triphosphateReactiongch1_step

Annotons

GCH1: GTP cyclohydrolase I
gch1_activity
Participant: Family: GTP cyclohydrolase I family (GCH1)
Family:
GTP cyclohydrolase I family (GCH1)PANTHER:PTHR11109
Representative Members: GCH1 (human)UniProtKB:P30793

Function

GTP cyclohydrolase I activityGO:0003934
Substrates: GTP
Products: 7,8-dihydroneopterin 3'-triphosphate formate

Locations

cytosolGO:0005829

Committed, rate-limiting and feedback-regulated first step of de novo BH4 synthesis (GCH1 is feedback-inhibited by BH4 via the GCH1-feedback regulatory protein GCHFR, and stimulated by phenylalanine). Dominant GCH1 mutations cause dopa-responsive dystonia (Segawa disease); recessive loss causes BH4-deficient hyperphenylalaninemia.

Part 2: de novo synthesis, second step
7,8-dihydroneopterin 3'-triphosphate to 6-pyruvoyltetrahydropterinReactionpts_step

Annotons

PTS/PTPS: 6-pyruvoyltetrahydropterin synthase
pts_activity
Participant: Family: 6-pyruvoyltetrahydropterin synthase family (PTS/PTPS)
Family:
6-pyruvoyltetrahydropterin synthase family (PTS/PTPS)PANTHER:PTHR12589
Representative Members: PTS (human)UniProtKB:Q03393

Function

6-pyruvoyltetrahydropterin synthase activityGO:0003874
Substrates: 7,8-dihydroneopterin 3'-triphosphate
Products: 6-pyruvoyl-5,6,7,8-tetrahydropterin triphosphate

Locations

cytosolGO:0005829

Zinc- and magnesium-dependent triphosphate elimination / rearrangement converting dihydroneopterin triphosphate to 6-pyruvoyltetrahydropterin. PTS deficiency (PTPS deficiency) is the most common cause of BH4-deficient hyperphenylalaninemia.

Part 3: de novo synthesis, terminal reduction to BH4
6-pyruvoyltetrahydropterin to tetrahydrobiopterin (BH4)Reactionspr_step

Annotons

SPR: sepiapterin reductase
spr_activity
Participant: Family: Sepiapterin reductase family (SPR)
Family:
Sepiapterin reductase family (SPR)PANTHER:PTHR44085
Representative Members: SPR (human)UniProtKB:P35270

Function

sepiapterin reductase (NADP+) activityGO:0004757
Substrates: 6-pyruvoyl-5,6,7,8-tetrahydropterin NADPH
Products: tetrahydrobiopterin (BH4) NADP+

Locations

cytosolGO:0005829

Terminal NADPH-dependent reductions producing BH4. In tissues that lack SPR, alternative "salvage" enzymes (aldo-keto reductases, carbonyl reductase) can complete the last reductions, so SPR deficiency is dominated by central monoamine-neurotransmitter deficiency (dopa-responsive dystonia) rather than hyperphenylalaninemia.

Part 4: BH4 utilization (regenerates the substrate for the recycling arm)
aromatic amino acid hydroxylation consumes BH4, producing pterin-4a-carbinolamineReactionaaah_utilization

Annotons

PAH / TH / TPH: BH4-dependent aromatic amino acid hydroxylases
aaah_activity
Participant: Family: Biopterin-dependent aromatic amino acid hydroxylase family (PAH, TH, TPH1/2)
Family:
Biopterin-dependent aromatic amino acid hydroxylase family (PAH, TH, TPH1/2)
Representative Members: PAH (human, phenylalanine hydroxylase)UniProtKB:P00439 TH (human, tyrosine hydroxylase)UniProtKB:P07101 TPH1 (human, tryptophan hydroxylase 1)UniProtKB:P17752 TPH2 (human, tryptophan hydroxylase 2)UniProtKB:Q8IWU9

Function

reduced-pteridine-dependent aromatic amino acid monooxygenase activityGO:0016714
Substrates: aromatic amino acid (Phe / Tyr / Trp) tetrahydrobiopterin (BH4) dioxygen
Products: hydroxylated amino acid pterin-4a-carbinolamine (4a-hydroxy-BH4)

Locations

cytosolGO:0005829

Not part of BH4 synthesis, but the reason BH4 must be regenerated: each hydroxylation of an aromatic amino acid oxidises BH4 to pterin-4a-carbinolamine, which is the substrate that enters the PCBD1-QDPR recycling loop. Represented generically by the biopterin-dependent aromatic amino acid hydroxylase family.

Part 5: regeneration, dehydration of the carbinolamine
pterin-4a-carbinolamine to quinonoid dihydrobiopterin + H2OReactionpcbd1_step

Annotons

PCBD1/PCD: pterin-4a-carbinolamine dehydratase
pcbd1_activity
Participant: Family: Pterin-4-alpha-carbinolamine dehydratase / DCoH family (PCBD1/PCBD2)
Family:
Pterin-4-alpha-carbinolamine dehydratase / DCoH family (PCBD1/PCBD2)PANTHER:PTHR12599
Representative Members: PCBD1 / DCoH (human)UniProtKB:P61457 PCBD2 / DCoHm (human paralog)UniProtKB:Q9H0N5

Function

4-alpha-hydroxytetrahydrobiopterin dehydratase activityGO:0008124
Substrates: pterin-4a-carbinolamine (4a-hydroxy-BH4)
Products: quinonoid dihydrobiopterin water

Locations

cytosolGO:0005829

First step of BH4 regeneration: dehydrates the pterin-4a-carbinolamine produced by the hydroxylases to quinonoid dihydrobiopterin (also suppresses the side production of 7-biopterin / primapterin). PCD deficiency causes a mild/transient hyperphenylalaninemia with primapterinuria. The same protein moonlights as DCoH, stabilizing the HNF1 transcription-factor dimer in the nucleus (a distinct function represented in the PCBD1 gene review, not in this metabolic module).

Part 6: regeneration, NADH-dependent reduction back to BH4
quinonoid dihydrobiopterin + NADH to tetrahydrobiopterin (BH4)Reactionqdpr_step

Annotons

QDPR/DHPR: dihydropteridine reductase
qdpr_activity
Participant: Family: Dihydropteridine reductase family (QDPR/DHPR)
Family:
Dihydropteridine reductase family (QDPR/DHPR)PANTHER:PTHR15104
Representative Members: QDPR (human)UniProtKB:P09417

Function

6,7-dihydropteridine reductase activityGO:0004155
Substrates: quinonoid dihydrobiopterin NADH
Products: tetrahydrobiopterin (BH4) NAD+

Locations

cytosolGO:0005829

Terminal step of BH4 regeneration: NADH-dependent reduction of quinonoid dihydrobiopterin back to BH4, the quantitatively dominant route of BH4 supply during active hydroxylase turnover. DHPR deficiency is a BH4-deficient hyperphenylalaninemia with severe monoamine-neurotransmitter deficiency requiring BH4 plus neurotransmitter-precursor therapy (not diet alone).